Tuberc Respir Dis.
2022 Jul;85(3):279-282. 10.4046/trd.2022.0020.
Current Chronic Obstructive Pulmonary Disease Treatment Status in Asia: A Position Statement of the Asian Pacific Society of Respirology
- Affiliations
-
- 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 2University of British Columbia Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, BC, Canada
- 3Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada
- 4Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
- 5Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan National Respiratory Center Hospital, Jakarta, Indonesia
- 6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 7Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Japan
- KMID: 2531458
- DOI: http://doi.org/10.4046/trd.2022.0020
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
- 11th Combined Meeting Asia Pacific Spine Society & Asia Pacific Paediatric Orthopaedic Society
- Risk Factors of Chronic Obstructive Pulmonary Disease (COPD)
- Allergic rhinitis, chronic rhinosinusitis and nasal polyposis in Asia Pacific: impact on quality of life and sleep
- Cor Pulmonale with Particular Reference to Chronic Obstructive Pulmonary Disease and Pulmonary Tuberculosis
